Linda Llewelyn - Jan 4, 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief People Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Jan 4, 2022
Transactions value $
-$95,006
Form type
4
Date filed
1/6/2022, 08:07 PM
Previous filing
Dec 7, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $22.1K +2.05K +6.62% $10.80 33K Jan 4, 2022 Direct
transaction HCAT Common Stock Options Exercise $13K +1.1K +3.33% $11.78 34.1K Jan 4, 2022 Direct
transaction HCAT Common Stock Sale -$130K -3.23K -9.48% $40.23 30.9K Jan 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -1.1K -18.79% $0.00 4.75K Jan 4, 2022 Common Stock 1.1K $11.78 Direct F2
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -2.05K -22.85% $0.00 6.92K Jan 4, 2022 Common Stock 950 $10.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
F2 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
F3 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.